Peter Huang
Directeur Technique/Scientifique/R&D chez ZAI LAB LIMITED
Provenance du réseau au premier degré de Peter Huang
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
| Public Company | Biotechnology | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Huang via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMETRIX, INC. | Medical Specialties | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Compliance Officer | |
| CVS HEALTH CORPORATION | Drugstore Chains | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Hong Kong Polytechnic University | College/University | Undergraduate Degree Graduate Degree | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Peking Union Medical College | College/University | Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Matrix Capital Management Co. LP
 Matrix Capital Management Co. LP Investment ManagersFinance Matrix Capital Management Co. LP (Matrix) is an independent registered investment adviser and hedge fund manager headquartered in Waltham, Massachusetts. The firm was founded by David E. Goel and Paul J. Ferri in 1999. Matrix serves as the manager or management firm, as the case may be, with discretionary investment authority to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Fudan University | College/University | Corporate Officer/Principal Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree Graduate Degree | |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member | |
| Texas Tech University | College/University | Undergraduate Degree | |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
| NEON THERAPEUTICS, INC. | Biotechnology | President | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | President | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
| SYNTHORX, INC. | Biotechnology | Corporate Officer/Principal | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Analyst-Equity |
Statistiques
Internationale
| Etats-Unis | 44 |
| Chine | 4 |
| Canada | 2 |
| Hong Kong | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 15 |
| Commercial Services | 10 |
| Finance | 4 |
| Retail Trade | 2 |
Opérationnelle
| Director/Board Member | 178 |
| Corporate Officer/Principal | 80 |
| Independent Dir/Board Member | 58 |
| Undergraduate Degree | 32 |
| Chairman | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Lonnie Moulder | 31 |
| John D. Diekman | 29 |
| Wing Yu Leung | 27 |
| Tony Sun | 20 |
| Kai Xian Chen | 20 |
| David Goel | 18 |
| Scott Morrison | 16 |
| Peter Wirth | 15 |
| Melissa Epperly | 13 |
| Kimberly Blackwell | 13 |
| Enoch K. Kariuki | 13 |
| William Lis | 12 |
| Richard Gaynor | 11 |
| David Johnson | 11 |
| Karan Takhar | 11 |
- Bourse
- Insiders
- Peter Huang
- Connexions Sociétés
